FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Teprotumumab-trbw
Status: Currently in Shortage
»Date first posted: 12/23/2020
»Therapeutic Categories: Ophthalmology

Horizon Therapeutics (New 12/23/2020)

Company Contact Information:
1-866-479-6742

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg lyophilized powder (NDC 75987-130-15) Product unavailable; Shortage anticipated to last through Q1 2021 Manufacturing delays due to limited capacity at manufacturing facility Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English